The US Tissue Plasminogen Activator Market is supported by established emergency medical services, advanced hospital infrastructure, and continued investment in stroke care. Healthcare providers use tissue plasminogen activator therapies for eligible patients experiencing acute ischemic stroke when clinical criteria are satisfied. Improvements in diagnostic imaging, emergency department...